chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient has reacted poorly to all COVID vaccines to date, with each reaction being different in symptoms.; This spontaneous case was reported by a patient and describes the occurrence of IMMUNISATION REACTION (Patient has reacted poorly to all COVID vaccines to date, with each reaction being different in symptoms.) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient had no comorbidities and was currently not taking any medication.  Previously administered products included for Product used for unknown indication: Pfizer (Dose 2) and Pfizer (Dose 1). Past adverse reactions to the above products included Vaccination adverse reaction with Pfizer and Pfizer.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Patient has reacted poorly to all COVID vaccines to date, with each reaction being different in symptoms.). At the time of the report, IMMUNISATION REACTION (Patient has reacted poorly to all COVID vaccines to date, with each reaction being different in symptoms.) outcome was unknown.            Concomitant medication was not provided. Patient experienced negative side effects following the fourth COVID booster vaccine (bi-valent) with Pfizer. These side effects included muscle aches, headache and chills for one day as well as a red, swollen, itchy, and warm injection site (commonly known as COVID arm) for approximately three days. Treatment information was not reported.
Within a week after first vaccine dose, burning in legs from above the knee to feet. Numbness and tingling in fingers and feet. Symptoms continue. Within a week after second vaccine,  onset of bilateral upper quadrant pain, thoracic and flank pain that worsened over time.  Unable to lie down due to sharp pain. Reached out to Oncology and PCP offices after symptoms of both vaccines for awareness and guidance. 5/4/21 - Emergency and inpatient visit - diagnosed with bilateral pulmonary emboli.
pulmonary embolism chest pain shortness of breath, blood thinner given patient sent home on o2 and blood thinner still non o2.
Got vaccinated and still got it twice/Suspected vaccination failure; Got it twice, Shingles are the worst; Got it twice, Shingles are the worst; Pain that is constant and just does not go away.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and shingles were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, shingles and pain to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this report. The age at vaccination was not reported. The patient got vaccinated and still got shingles twice.  The patient had the kind of pain that was constant and just did not went away. The patient asked that the shingles were worst. This case was considered as suspected vaccination failure as details regarding the completion of primary vaccination schedule, time to onset and laboratory test confirmation for shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Discharge Provider: MD Primary Care Provider: NP Admission Date: 10/12/2022 Discharge Date: Oct 18, 2022  PRESENTING PROBLEM: Atrial fibrillation with RVR (HCC) [I48.91] COVID-19 [U07.1]   HOSPITAL COURSE: Patient is a 79 yo male with PMH of afib, dilated cardiomyopathy, diastolic heart failure, IDDM2, CAD, essential HTN and dementia (non-verbal for last 2 years). He presented to the ED from his home due to fever and after testing positive for COVID-19.   In the ED, patient was noted to be in afib with RVR with CXR without acute cardiopulmonary process. He was treated with Lopressor and initial plan was for discharge back to facility given lack of hypoxia, but heart rate remained >120 and required additional dose of IV Cardizem. Due to difficulty controlling heart rate patient was admitted to the medicine service.   # Chronic Atrial Fibrillation Presented with RVR secondary to COVID-19 infection and home Digoxin was discontinued due to elevated levels. He was continued on his home Xarelto and started on Metoprolol succinate which allowed him to be weaned from Caredizem gtt. Echo was obtained but very limited due to limited views. Patient did develop bradycardia with Metoprolol succinate and therefore dose was reduced at time of discharge.   # COVID-19 PNA with Superimposed Bacterial Infection patient was noted to be hypoxic during hospitalization and therefore started on Decadron and Remdesivir. Repeat CXR demonstrated interstitial opacities and pro-calcitonin was noted to be elevated to 0.66. He completed 1.5 gm of Azithromycin and 5 days of IV Ceftriaxone while hospitalized. He was able to wean off oxygen prior to discharge but was discharged on decadron (6 mg daily) to complete total of 10 days due to inability to verbalize symptoms   # IDDM2 Endocrinology was consulted during hospitalization due to difficulty to control blood sugars secondary to decadron and provided recommendations for discharge.
Initially sore arm had gone away after a day but about 10 days later injection site was sore to touch and became red, slightly raised, and itchy.
Woke up at 2:30 am unable to breathe well, hoarse voice, racing heart, sweating, coughing, etc. Immediately took 5 mg of prednizone and two benadryl. Had an old albuterol inhaler from bronchitis a few years ago and used that.  Symptoms continue 23 hours later, but prednizone, benadryl, and albuterol are helping. Still short of breath and difficult to breathe. Joint aches. Bad headache.   Father is a physician and consulted with him. Also consulted with a pharmacist at pharmacy and my mother-in-law, a nurse practitioner and former ER nurse on what to do.
Breakthrough case admission after 5 vaccines Moderna 1/26/21 Lot# 032420A;  Moderna 2/23/21 Lot# 011M20A;  Moderna 12/9/21 LOt# 031H21A;  MOderna 4/26/22 Lot# 083J21A;  Moderna 10/31/22 Lot# 057F22A
Participant was vaccinated at 11:18 am.  At 11:48 c/o difficulty swallowing "I can only feel the left side of my throat".  Vitals at 11:50:  BP 120/84, HR 62, RR 18, lungs CTA, temp 98.2F.  A&O x 3.   Stated that on 12/30/20 rcvd Moderna first dose;had hives on flank and elbows the next day. Informed her PCP who referred her to allergy specialist; Allergist stated it was OK for her to return to this vaccine POD for 2nd dose. Monitored by EMS .  No medications were given. At 12:42 participant stated that she felt better, no symptoms.  She was released from post-vaccination area.
Three days following Covid-19 booster dose seen in the ED with stroke symptoms.  Transferred for acute care.  Transferred back to Inpatient Rehab unit on 11/19/2021 for treatment of  left nondominant hemiparesis secondary to acute CVE, Dysphasia secondary to acute CVA and cognitive deficits socondary to acute CVA.  Had no reports of adverse effects following the First (2/12/2021) and second (3/16/2021) Moderna vaccinations.
While I have suffered from Migraines during the course of my life, the Migraines I experience now are massively worse since I received the 1st covid19 vaccine. I am now medicated for the Migraines, which feel like a jolt of electricity  is being punched through the back of my brain. The pain is fast, sudden, and debilitating, My headaches have NEVER been this sever before the vaccines.  It affects my vision, knocks our my hearing in my left ear, and makes my equilibrium off to the point where I fall in to the walls while I am walking. IT is debilitating, painful, and the doctors I have spoken with prescribed me MaxAlt, which helps significantly. As I said, the pain has never been this intense before. IT has tanked my quality of life, and I wish I never got the vaccines.
The day after I received the vaccine and currently I have felt feverish, joint aches especially my knees, fatigue to the point where I have to miss work. I'm usually a very active person but not I barely get through the day. This has been going on for 7 days so far.
Swollen left thigh started on 12/31/14 after vaccine given on 12/30/2014. Mild redness at site; no fever, no streaking, blanching circular rash. Prescribed: Triamcinolone Acetonide cream and BENADRYL liquid.
Having altered smell and taste; Having altered smell and taste; This is a spontaneous report received from contactable reporter(s) (Pharmacist). The reporter is the patient.  A 49 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 26Feb2021 (Lot number: EL9266) at the age of 49 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Autoimmune disease" (unspecified if ongoing), notes: Verbatim: Autoimmune disease; "Allergies" (unspecified if ongoing), notes: Verbatim: Allergies; "COVID-19" (unspecified if ongoing), notes: Verbatim: if Covid prior vaccination: Yes. Concomitant medication(s) included: VENLAFAXINE; HYDROXYCHLOROQUINE. The following information was reported: TASTE DISORDER (non-serious), PAROSMIA (non-serious) all with onset 28Feb2021, outcome "not recovered" and all described as "Having altered smell and taste". Therapeutic measures were not taken as a result of taste disorder, parosmia.  Additional information: Had no seriousness criteria-resulted in death, no seriousness criteria was life threatening, no seriousness criteria-caused/prolonged hospitalization, no seriousness criteria was disabling/incapacitating, no seriousness criteria caused congenital anomaly/birth defect, had no other vaccine in four weeks, other medications in two weeks included: low ogestrel, los. Patient was not able to stand to be within certain smells. Coffee, meat, onions, white wine, soda, and all fried food  were just some examples. He was impaired to the point he could not eat some meals with her family. Not received  treatment ae, had covid prior vaccination, had not covid tested post vaccination. no timestamp: 16nov2021.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was vaccinated with VARIVAX (Merck) (lot number 671130/1220AA, expired date 26-JUL-2012) (dose and route were not reported) on 17-JUL-2012. No other co-suspects were reported. No concomitant medications were reported. The reporter stated that the patient received an improperly stored VARIVAX (Merck), the vaccine has been stored in the refrigerator since it was received in the pharmacy in February 2012. No adverse symptoms reported. It was unspecified if the patient had sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
About 15 minutes after getting the shot I got a metallic taste in my mouth. That metallic taste lasted almost 6 weeks. It comes back sporadically, and when it comes back it lasts between one day and a week. The lymph node under my left arm swelled to larger than a softball. I couldn't put my arm down. And that started on 4/21. And it took 2 weeks for the swelling to go down under my arm. And occasionally and sporadically, it'll slightly swell, hurt for a day, and then go away. I had swelling ¾ of the way across my chest. The swelling was significant. It was approx. 2 inches high. Husband said it looked like I had 3 breasts. That lasted for 2 and a half weeks also. With the swelling came a lot of chest pressure, and I still have chest pressure occasionally now, which caused me to go to my cardiologist. I will say at the time, we had a lot of COVID in my area so I didn't go to the hospital because I was scared to. But it took a while to get into the doctor, so my doctor did not see the complete swelling but there was still some there. When I went to my cardiologist (I go every 6 months) and he does an EKG. This time there was a slight minimal difference in my EKG. A stress test didn't show anything, but there is a slight glitch in my heart beat. My EKG prior to the vaccine was 2 weeks prior, so since the pressure and everything started after the vaccine, that's why I'm relating the heart pressure and everything to the vaccine and the swelling and everything that I had. During all of this, I took aspirin and Benadryl. Since I couldn't get to any doctor. My doctor has told me that her professional advice was not to get the second dose of the vaccine for the risk of anaphylaxis.
pt recv vax 29JAN97 & 2FEB97 pt was exp arthralgic type rxn in the knees, hips & fingers;pt had never been pre immunized a/this exp happened p/1st does;hx of arthritis;
over 42 days, first dose 06/11/21, second dose 07/26/21
This spontaneous case was reported by a consumer and describes the occurrence of UPPER LIMB FRACTURE (Had 5 fractures in her shoulder), HUMERUS FRACTURE (Humerus bone was turned), PYREXIA (fever/third dose was worse than the first two), MYALGIA (body aches/third dose was worse than the first two) and NAUSEA (nausea (3days)/third dose was worse than the first two) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012F21A, 027A21A and 036B21A) for COVID-19 vaccination. Concurrent medical conditions included Immunocompromised.On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form.On 24-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced UPPER LIMB FRACTURE (Had 5 fractures in her shoulder), HUMERUS FRACTURE (Humerus bone was turned), PYREXIA (fever/third dose was worse than the first two), MYALGIA (body aches/third dose was worse than the first two) and NAUSEA (nausea (3days)/third dose was worse than the first two). At the time of the report, UPPER LIMB FRACTURE (Had 5 fractures in her shoulder) and HUMERUS FRACTURE (Humerus bone was turned) had not resolved, PYREXIA (fever/third dose was worse than the first two) and MYALGIA (body aches/third dose was worse than the first two) outcome was unknown and NAUSEA (nausea (3days)/third dose was worse than the first two) had resolved. The  concomitant medications on use were not provided.The patient reported that she was immunocompromised. Patient stated that the third dose was worse than the first two. Patient had 5 fractures in her shoulder and her humerus bone was turned. Patient stated that her doctor told her to let it heal.No treatment information was provided. This case was linked to MOD-2022-533476, MOD-2022-533467 (Patient Link).
This spontaneous report as received from a pharmacist concerning a 65 year old male patient who on 10-AUG-2012 was vaccinated with a single dose 0.65 ml subcutaneous in her left deltoid ZOSTAVAX (lot number 671018/0748AA, expiration date 18-OCT-2013). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that the patient reported an area of an inch and a half of itching, redness and a big round raised welt at the injection site of administration. No treatment information was reported. At the time of the report, the patient was recovering from the event. This is one of several report received from the same source (other case numbers 1208USA011818, 1208USA010432). Additional information has been requested.
Low grade fever and headache noted around 24 hours after vaccination. Resolved within around 24 hours of onset.; Low grade fever and headache noted around 24 hours after vaccination. Resolved within around 24 hours of onset.; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Apr2022 at 18:00 as dose 4 (booster), single (Lot number: FJ 4989) at the age of 58 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose: 01, Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 02, Unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose: 03, Unknown manufacturer), for COVID-19 Immunization.  The following information was reported: HEADACHE (non-serious), PYREXIA (non-serious) all with onset 22Apr2022 at 23:45, outcome "recovered" (Apr2022) and all described as "Low grade fever and headache noted around 24 hours after vaccination. Resolved within around 24 hours of onset.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of headache, pyrexia.  Additional Information: It was reported that other vaccine did not take within four weeks. Low grade fever and headache noted around 24 hours after vaccination. Resolved within around 24 hours of onset. Therapeutic measures were taken as a result of events include Tylenol. Patient was not reported with covid prior vaccination and was not tested with covid post vaccination.
her heart has been beating fast/Her heart is racing; She got a headache; But this is a strange one, like someone walking inside her head. All she feels bump bump bump; This is a spontaneous report from a contactable consumer or other non hcp.   A 72-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VAC-CINE, formulation: Solution for injection, Batch/lot number: ENO158 expiration date: unknown) via an unspecified route of administration in Arm Left on 29Jun2021 14:00 (age at vaccination 72years old) as single dose for covid-19 immunization. The patient did not have any medical history. Concomitant medications were not reported. She received the first dose of the covid vaccine about 14:00, she got home and about an hour and a half at about 17:36, she got headache. It was a big headache, and her head was thumping. It was stated that she would get headaches sometimes, but this was a strange one, like someone walking inside her head. All she felt "bump bump bump". Her heart was racing: After she ate something, her heart started pumping, and it has not stopped. She wanted to know if this was normal. Confirmed that her heart started racing a day prior to this report (yesterday, not today)   It was stated that she just realized it was better to get the vaccine, than to have covid. Her and her husband got vaccinated. Therapeutic measures were taken as a result of a events. The outcome of the event was reported as not resolved.  No follow-up attempts were needed. No further information was expected.
Patient observed for 15 minutes, then went to her car with her daughter, then started having slurred speech, right eye twitching and right hand clenching.
This spontaneous report as received from a registered nurse refers to multiple unspecified patients of unknown age and gender. No information regarding the patients' medical history, concurrent conditions or concomitant therapies was reported. On multiple unspecified dates, the patients were vaccinated with improperly stored (temperature 23.7 Fahrenheit degrees (F), time frame reported as cumulative total of 14 hours and 45 minutes, also reported as vaccine temperature excursion) doses of PROQUAD (Merck) injection (lot# L014405 with expiration date 23-OCT-2016, lot# L033698 with expiration date 28-FEB-2017, lot# L023112 with expiration date 24-DEC-2016, lot# L034931 with expiration date 03-MAR-2017, lot# L046507 with expiration date 17-MAY-2017 and lot# L051098 with expiration date 16-JUN-2017, therapy type, dose and route of administration were not reported). No adverse effect was reported. There was no previous temperature excursion. The call was made because of data logger. This is one of two reports received from the same reporter. Additional information has been requested.
neck pain, stiffness, insomnia, chills, sweat onset 48hr p/vax;
This spontaneous report as received from a physician via a company representative refers to 3 unspecified patients in their sixties (adult patients). No information regarding their concurrent conditions and medical history was provided. On an unknown dates, the patients were vaccinated with ZOSTAVAX refrigerated vial 19400 PFU, subcutaneously (lot # not reported). Concomitant medication was not mentioned. On an unknown dates, all the three patients developed shingles post vaccination with ZOSTAVAX. The patients sought medical attention by visiting the physician's office. The physician reported that the patients were all doing well now, but did not provide a specific time when the patients recovered. Causality assessment was not provided by the reporter. No product quality complaint was reported. It was also reported that the therapy with ZOSTAVAX was not discontinued. Additional information is not expected as the reporter did not wish further contact.
Difficulty swallowing, tongue swelling, headache,  Epi pen 0.3mg, 25 mg Benadryl Improvement in tongue swelling
Vivid Dreams Body felt like I was hit by a truck. Had trouble getting around. Pain and stiffness throughout body.  This was at 3am At 6am when I woke up, I felt like there was a band around my right calf, and there was shooting pains through my left foot / ankle  The second night, I woke up at 3am in a night sweat and feverish. Headache and vivid dreams.
This is a spontaneous report from a contactable consumer and contactable nurse. A 2 years old male patient received a dose of PREVNAR 13 (Lot # E57642, Expiration date: 11/2011) at 0.5 ml single dose at 3 month on 26Jul2010 (Lot n. E57642, exp. Date Nov2011), at 5 months on 29Sep2010 (Lot n. E80082, exp. Date Dec2011), at 7 months on 22Nov2010 (Lot n. E82385, exp. Date 23Aug2011) and at 16 months on 23Aug2011 (Lot n. E70195, exp. Date 31Jul2012), intramuscularly. The patient also received HIB vaccine on 26Jul2010 (Lot n. UH045AB, exp. Date 09Jun2012), on 29Sep2010 (Lot n. UH158AA, exp. Date Sep2012), on 22Nov2010 (Lot n. UH166AA, exp. Date Oct2012) and on 23Aug2011 (Lot n. UH318AA, exp. Date Mar2013), intramuscularly. The patient had no known drug allergies. Relevant medical history and concomitant medications were not reported. On 10May2012 the patient had a severe pneumococcal infection and was hospitalized. The nurse stated that patient was seen in ER (Emergency Room) on 10May2012 then was seen in Primary Care Office on 15May2012 and 16May2012 and sent directly to hospital with subsequent transfer to another hospital. Patient was diagnosed with Streptococcal Pneumonia related Hemolytic Uremic Syndrome and was admitted on 17May2012 and discharged on 26May2012. At the time of this report, therapeutic measure taken in response to the event was unknown. The patient was recovered from the event. Follow-up attempts completed. No further information expected. Follow-up (26Jun2012): New information received from a female Nurse includes: lot # confirmation. Follow-up (16Aug2012): New information received includes patient's demographic, vaccinations and events details. Hemolytic Uremic Syndrome was added as adverse event.
On 9-19-14 patient presented an apparent adverse reaction approx. 24 hours after receiving PNEUMOVAX 23 and FLUVIRIN on the left upper arm; area was red, warm to the touch and sore lump underneath the skin. Patient complained of feeling lousy and achy all over. Patient went to urgent care and returned with 3 prescriptions.